J1930 Lanreotide injection
Also known as: lanreotide, Somatuline
Injection of lanreotide. A synthetic somatostatin analog used for neuroendocrine and growth hormone conditions.
In Plain Language
somatostatin medication; growth hormone inhibitor injection
Clinical Context
Used for acromegaly, gastroenteropancreatic neuroendocrine tumors, and thyroid cancer. Lanreotide suppresses growth hormone and other hormone secretion.
RVU Information
CPT J1930 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1930?
CPT J1930 (Lanreotide injection) is a J Codes (Drugs) code. Injection of lanreotide. A synthetic somatostatin analog used for neuroendocrine and growth hormone conditions.
How is J1930 administered?
CPT J1930 is administered by a healthcare provider, typically via injection or infusion. Used for acromegaly, gastroenteropancreatic neuroendocrine tumors, and thyroid cancer. Lanreotide suppresses growth hormone and other hormone secretion. It is used by Endocrinology, Oncology, Gastroenterology.
When is CPT J1930 used?
Used for acromegaly, gastroenteropancreatic neuroendocrine tumors, and thyroid cancer. Lanreotide suppresses growth hormone and other hormone secretion.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.